Skip to main content

Table 2 Psoriasis scores, physician’s score, patient-reported outcomes among participants with or without musculoskeletal pain

From: The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis

Scores

Groups

P value*

No pain (n = 27)

median (min-max)

MSKa Pain (n = 16)

median (min-max)

PASIb

2 (0–30.2)

5.4 (0.8–16.5)

<  0.01

NAPSIc

9 (3–36)

18 (8–36)

<  0.001

PhysMSK VASd

0 (0–0)

1.5 (0–5)

<  0.001

Patient Global VAS

0.5 (0–5.1)

3 (0–9)

0.04

Pain VAS

0 (0–5)

2 (0–9)

<  0.01

CHAQe

0 (0–0.5)

0.1 (0–1.4)

<  0.001

CDLQIf

1 (0–13)

6 (1–21)

<  0.001

PedsQLg 4.0 - Total Score

85.1 (63.6–100.0)

69.7 (10.6–94.2)

<  0.001

PedsQL 4.0 - Physical Health

93.7 (59.4–100)

71.8 (12.5–96.9)

<  0.001

PedsQL 4.0 - Emotional Functioning

77.5 (30–100)

50 (5–90)

<  0.01

PedsQL 4.0 - Social Functioning

92.5 (70–100)

85 (20–100)

0.04

PedsQL 4.0 – School Functioning

80 (50–100)

65 (5–90)

<  0.01

PedsQL 4.0 - Psychosocial Health

81.7 (0–100.0)

64.2 (0–93.3)

<  0.01

PedsQL-MFSh - Total Fatigue

86.8 (51.4–100)

60.4 (6.9–8.7)

<  0.001

PedsQL-MFS – General Fatigue

91.6 (58.3–100)

64.6 (12.5–100)

<  0.01

PedsQL-MFS – Sleep/Rest Fatigue

87.5 (50–100)

64.6 (4.2–83.3)

<  0.001

PedsQL-MFS – Cognitive Fatigue

81.2 (8.3–100)

50.0 (4.2–91.6)

0.04

  1. aMSK musculoskeletal, bPASI Psoriasis Area and Severity Index, cNAPSI Nail Psoriasis Severity Index, dPhysMSK VAS Physician musculoskeletal Visual Analog Scale, eCHAQ Childhood Health Assessment Questionnaire, fCDLQI Children Dermatology Life Quality Index, gPedsQL Pediatric Quality of Life Inventory, hPedsQL-MFS Pediatric Quality of Life Inventory- Multidimensional Fatigue Scale
  2. *Mann-Whitney U test